6 research outputs found

    Radiation Exposure Aspects during Trans-Radial Angiography and Angioplasty

    Get PDF
    No Abstract

    Comparison of the patient radiation exposure during coronary angiography and angioplasty procedures using trans-radial and trans-femoral access

    No full text
    Introduction: Cardiac catheterization procedure through the trans-radial access (TRA) have shown many clinical advantages over the trans-femoral (TFA), but despite its advantages, there are serious concerns regarding higher possible radiation dose for the patients and operators in TRA. This study was planned to compare the patients’ radiation dose associated with TRA and TFA during coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA). Methods: Of 700 candidates for angiography, 326 patients were entered the study. All the procedures were carried out by one interventional cardiologist employing the same angiography unit in Aalinasab hospital and the patients’ dose area product (DAP), air kerma (AK), fluoroscopy time (FT) and cine film time (CFT) were then determined in both access groups (TRA,TFA) in CA, PTCA and CA+PTCA procedures. Results: The mean FT, CFT and AK values in both TRA & TFA groups were the same in all procedures (P > 0.05). The mean DAP in CA+PTCA procedures was 6704.01 ± 3243.23 µGym2 in femoral access compare with 5647.46 ± 2797.74 µGym2 in radial access, which were significantly less than that in TFA with P = 0.02. Conclusion: On the basis of the results obtained in this study, no differences were found in patients’ radiation dose in both access groups, therefore with regard to comparatively more clinical advantages associated with the Trans-radial access technique it might be a good substitute for Trans-femoral access

    Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.

    No full text
    High-frequency oscillations of the frontal cortex are involved in functions of the brain that fuse processed data from different sensory modules or bind them with elements stored in the memory. These oscillations also provide inhibitory connections to neural circuits that perform lower-level processes. Deficit in the performance of these oscillations has been examined as a marker for Alzheimer's disease (AD). Additionally, the neurodegenerative processes associated with AD, such as the deposition of amyloid-beta plaques, do not occur in a spatially homogeneous fashion and progress more prominently in the medial temporal lobe in the early stages of the disease. This region of the brain contains neural circuitry involved in olfactory perception. Several studies have suggested that olfactory deficit can be used as a marker for early diagnosis of AD. A quantitative assessment of the performance of the olfactory system can hence serve as a potential biomarker for Alzheimer's disease, offering a relatively convenient and inexpensive diagnosis method. This study examines the decline in the perception of olfactory stimuli and the deficit in the performance of high-frequency frontal oscillations in response to olfactory stimulation as markers for AD. Two measurement modalities are employed for assessing the olfactory performance: 1) An interactive smell identification test is used to sample the response to a sizable variety of odorants, and 2) Electroencephalography data are collected in an olfactory perception task with a pair of selected odorants in order to assess the connectivity of frontal cortex regions. Statistical analysis methods are used to assess the significance of selected features extracted from the recorded modalities as Alzheimer's biomarkers. Olfactory decline regressed to age in both healthy and mild AD groups are evaluated, and single- and multi-modal classifiers are also developed. The novel aspects of this study include: 1) Combining EEG response to olfactory stimulation with behavioral assessment of olfactory perception as a marker of AD, 2) Identification of odorants most significantly affected in mild AD patients, 3) Identification of odorants which are still adequately perceived by mild AD patients, 4) Analysis of the decline in the spatial coherence of different oscillatory bands in response to olfactory stimulation, and 5) Being the first study to quantitatively assess the performance of olfactory decline due to aging and AD in the Iranian population

    Trade-off between breast mean glandular dose and image quality in digital and conventional mammogram systems: A multicenter study

    No full text
    Evaluating the patient dose or exposure parameters considering the image quality can improve the chances of accurate diagnosis and reduce the unnecessary exposures from medical devices such as mammography. This study aimed to evaluate digital and conventional mammography machines while considering the trade-off between image quality and mean glandular dose (MGD) using a phantom. In the present study, one full-field digital mammography (FFDM) and two film-screen mammography (FSM) machines were investigated. The MGD values and image quality were assessed using the American College of Radiology (ACR) phantom at various mAs and constant kVp values. The results were obtained and compared with European guidelines. Friedman and Wilcoxon statistical tests were used to show the comparison. The results from the quality control (QC) tests demonstrated that all machines are functioning well. The best image quality in the digital mammography machine was observed at the MGD of 1.8 mGy and 55 mAs. In addition, the two conventional machines had the best image quality regarding the imaging of the ACR phantom at 65 mAs with an MGD of 2.1 mGy. These values were considered as appropriate values for the studied mammography systems. Furthermore, the Friedman test demonstrated that there are significant differences between the measured image quality values obtained from the different machines (p < 0.05), however, according to the Wilcoxon test there were not any significant differences between the conventional machines at various mAs values. Owing to the results, for a medium breast size, the image quality will not be improved with increasing the exposure after a specified MGD corresponds to a certain mAs. It is notable that this value is smaller in digital mammography system at a reasonably low dose
    corecore